Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study

SIMPLE SUMMARY: FOLFIRINOX, which is a first-line chemotherapy for metastatic pancreatic cancer, has become one of the high-risk regimens related to developing febrile neutropenia (FN). Although UGT1A1 polymorphisms are associated with the metabolism of irinotecan, their role as surrogate markers fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Keum, Jiyoung, Lee, Hee Seung, Jo, Jung Hyun, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Bang, Seungmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909027/
https://www.ncbi.nlm.nih.gov/pubmed/35267552
http://dx.doi.org/10.3390/cancers14051244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909027/
https://www.ncbi.nlm.nih.gov/pubmed/35267552
http://dx.doi.org/10.3390/cancers14051244

Ejemplares similares